Get baseline bloodwork including fasting glucose, HbA1c, lipid panel, B12, thyroid function, liver enzymes, and kidney function
Developed by Eli Lilly, the same pharmaceutical company behind Tirzepatide, Retatrutide takes the dual agonist approach one step further by adding a third receptor target
Market Reaction On June 24, 2025, Hims stock fell 34.6%, closing at $41.98, down from $64.08 the prior day
During your visit, she will discuss the benefits and potential risks, answer your questions, and provide a prescription if Zepbound is appropriate for your health needs
To administer GLP-1 medication from a vial, first wash your hands and prepare a clean surface
No adverse events, such as diabetic ketoacidosis (DKA) or genital infections, were reported during the follow-up period